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Background: Liver cirrhosis is a very common disease in Egypt especially post hepatitis type, it
affects the quality of life and daily performance. It is associated with hypoxemia and impaired oxy-
gen consumption.
Methods: This study was conducted on 30 patients of liver cirrhosis and 10 healthy subjects (con-
trol group), they were selected from the Menouﬁa University Hospital. All subjects were subjected
to clinical history, clinical examination, plain chest-X-ray, blood sample for: complete blood pic-
ture, liver function tests, prothrombin time, abdominal ultrasonography and pulmonary function
tests (spirometry) and cardiopulmonary exercise tests.
Results: The results of this study revealed a signiﬁcant reduction of most parameters of exercise
test and pulmonary function tests in cirrhotic group versus the control group. Prevalence of exercise
impairment increased with the increase of the severity of liver cirrhosis.
Conclusion: (1) Cirrhotic patients have impaired exercise performance. (2) Prevalence of exercise
impairment increased with the increase of the severity of liver cirrhosis.
ª 2015 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis.Introduction
Cirrhosis is deﬁned histologically as a diffuse hepatic process
characterized by ﬁbrosis and the conversion of normal liver
architecture into structurally abnormal nodules. The progres-
sion of liver injury to cirrhosis may occur over weeks to years
[1]. Exercise capacity, which is also known as cardiorespiratory
ﬁtness and aerobic capacity, is the ability to consume and use
960 A.A. Ali et al.oxygen during exercise [2]. Maximal exercise capacity and pul-
monary gas exchange are both commonly impaired in liver cir-
rhosis. These impairments appear to be independent of the
etiology of cirrhosis, but the data are equivocal with respect
to their association with disease severity [3].
Aim of the study
The aim of the current study was to investigate the exercise
performance and cardiorespiratory efﬁciency in patients with
liver cirrhosis.
Methods
A written consent was obtained from all subjects prior to
inclusion and the regional ethics committee of the Menouﬁa
University hospital approved the study. The study was con-
ducted in the Menouﬁa University hospital, and involved
thirty patients with liver cirrhosis. The study also included
ten healthy controls.
Study subjects were divided into 3 groups according to
Child-Paugh classiﬁcation: Group A, included 12 patients;
Group B, included 11 patients; Group C, included 7 patients
with liver cirrhosis. All subjects were subjected to clinical his-
tory, clinical examination, plain chest-X-ray, blood sample for:
complete blood picture, liver function tests, prothrombin time,
abdominal ultrasonography and pulmonary function tests,
exercise test. In our study, the patients underwent pulmonary
function tests (PFT) 3 times: before exercise, immediate and
30 min after cardiopulmonary exercise. Ten healthy volunteers
who had no symptoms or signs of any chest disease and nor-
mal pulmonary function tests were included as a control
group.
Results
The comparison of cirrhotic patients and the control group
regarding pulmonary function test parameters revealed that,
there was signiﬁcant decline in FVC and Vt in the cirrhotic
group versus the control group, while it showed non signiﬁcant
difference in FEV1, FEV1/FVC, PEF, RF between the two
groups (Table 2). The comparison of cirrhotic patients and
the control group regarding the cardiopulmonary exercise test
parameters revealed that, there was signiﬁcant difference in
VO2/kg %, METS %, VO2/HR, Vd/Vt and SpO2 % regarding
the comparison of cirrhotic patients and the control group,Table 1 Comparison of cirrhotic patients and the control
group regarding pulmonary function test parameters.
Variables Cirrhotic patients Control group T test P-value
FVC 66.32 ± 1.83 69.75 ± 1.62 7.235 0.021*
FEV1 71.79 ± 3.51 71.82 ± 1.56 2.141 0.324
FEV1/FVC 80.26 ± 1.42 80.53 ± 1.22 4.651 0.861
PEF 55.92 ± 2.25 55.52 ± 1.38 3.116 0.127
FEF25–75% 76.10 ± 1.92 76.56 ± 1.75 6.821 0.833
RF 27.83 ± 2.05 27.54 ± 1.05 0.2468 0.614
Vt 0.48 ± 0.08 0.93 ± 0.09 4.152 0.042
*
* P is signiﬁcant if 0.05.while it shows non signiﬁcant difference in Pet CO2, Pet O2,
VE/CO2 and VE/O2 between the two groups (Table 2).
In this study, the comparison of oxygen uptake per kg ratio
(VO2/kg %) between the different groups of cirrhotic patients
revealed that, there was signiﬁcant difference between groups
(A, B) and (A, C), (B, C) regarding VO2/kg % (Table 3). In
our study, the comparison of oxygen saturation percent
(SpO2 %) between the different groups of cirrhotic patients
showed signiﬁcant difference between groups (A, B), (A, C)
and (B, C) regarding SpO2 % (Table 4).Discussion
CPET stresses both pulmonary and cardiovascular systems
simultaneously so many diseases or conditions that may not
be apparent at rest will show overt dysfunction during or after
exercise [1]. There is no doubt that gender and height are the
most important predictors of lung function. Height linearly
correlates with lung size [2].
In our study, comparison of cirrhotic patients and control
group regarding pulmonary function test parameters revealed
that, there was signiﬁcant decline in FVC and Vt in the cir-
rhotic group versus the control group, while there was non sig-
niﬁcant difference in FEV1, FEV1/FVC, PEF, RF between the
two groups (Table 1).
Shashikala et al. (2011) studied the effect of long term stress
exercises and sports activities on pulmonary function tests in
26 cirrhotic patients and 15 healthy volunteers, FVC, FEV1
FEV1/FVC and Vt values were higher in the volunteers, while
RF were higher in the cirrhotic patients.(189) qualiﬁed by relat-
ing speciﬁc parameters to oxygen consumption. [3] In this
study we found that, the comparison of cirrhotic patients
and the control group regarding the cardiopulmonary exercise
test parameters revealed that, there was signiﬁcant difference
in VO2/kg %, METS %, VO2/HR, Vd/Vt and SpO2 % regard-
ing the comparison of cirrhotic patients and the control group,
while there was non signiﬁcant difference in Pet CO2, Pet O2,
VE/CO2 and VE/O2 between the two groups (Table 2).
Many studies have examined the association between car-
diopulmonary exercise parameters (VO2/kg %, METS %,
VO2/HR, Vd/Vt, Pet CO2, Pet O2, VE/CO2 and VE/O2) in
patients with cirrhosis, and they have found a signiﬁcant
reduction in the exercise capacity and muscle strength of
patients with cirrhosis versus healthy controls. These impair-
ments appear to be independent of the etiology of cirrhosis,
but the data are equivocal with respect to their association
with disease severity [4–6].
Councilet et al. (2004) studied the clinical and physiological
effects of a medically supervised, indoor physical training pro-
gram for 6 months and investigated 26 chronic liver diseased
subjects aged 42–55 years. After training there was a signiﬁcant
increase in mean maximal oxygen uptake. These changes were
signiﬁcantly greater in the group undergoing training than in
the control group. The subjects motivation, the initial level
of ﬁtness, and the symptoms score at the time of training were
the most important factors inﬂuencing improvements in car-
diorespiratory ﬁtness. Thus submaximal physical exercise of
controlled intensity, sustained for three months produced sig-
niﬁcant improvements in ﬁtness and cardiorespiratory perfor-
mance that should be advantageous to the exercising patients
[7]. In this study, the comparison of oxygen uptake per kg ratio
Table 2 Comparison of cirrhotic patients and the control group regarding the cardiopulmonary exercise tests parameters.
Variables Cirrhotic patients Control group T test P-value
VO2/kg % 38.3 ± 2.61 53.42 ± 5.34 12.141 0.004
**
METS % 23.52 ± 4.12 53.14 ± 4.73 10.11 0.027*
Vd/Vt 56.73 ± 3.48 31.82 ± 3.54 8.821 0.003
**
HR % 56.53 ± 3.45 56.67 ± 3.76 4.152 0.432
VO2/HR ml/bpm 25.42 ± 8.36 41.59 ± 4.45 5.519 0.006
**
Pet CO2 mmHg 44.32 ± 8.73 44.21 ± 5.23 2.273 0.121
Pet O2 mmHg 87.23 ± 6.68 87.45 ± 4.56 3.309 0.345
VE/VCO2 45.78 ± 3.67 45.37 ± 3.32 4.114 0.114
VE/VO2 43.67 ± 4.62 43.72 ± 3.78 6.005 0.194
SpO2 % 71.32 ± 7.67 45.67 ± 3.78 7.119 0.0006
***
Table 3 Comparison of oxygen uptake per kg ratio (VO2/kg %) between the different groups of cirrhotic patients.
Variables Group A Group B Group C P-value Tukey’s test
n = 12 n = 11 n = 7
VO2/kg % 40.16 ± 1.72 38.12 ± 1.37 34.94 ± 2.08 60.05 P1 (A, B),
P2 (A, C),
P3 (B, C)
P1 means signiﬁcance between groups A and B.
P2 means signiﬁcance between groups A and C.
P3 means signiﬁcance between groups B and C.
Table 4 Comparison of oxygen saturation percent (SpO2 %) between the different groups of cirrhotic patients.
Variables Group A Group B Group C P-value Tukey’s test
n = 12 n = 11 n = 7
SpO2 % 80.42 ± 3.12 68.64 ± 5.24 59.86 ± 5.87 60.05 P1 (A, B),
P2 (A, C),
P3 (B, C)
P1 means signiﬁcance between groups A and B.
P2 means signiﬁcance between groups A and C.
P3 means signiﬁcance between groups B and C.
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revealed that, there was signiﬁcant difference between groups
(A, B) and (A, C), (B, C) regarding VO2/kg % (Table 3).
The VO2max provides a measure of the maximal amount of
oxygen which can be delivered to the tissues and is often taken
as a measure of the maximal exercise capacity [8]. Also VO2max
serves as the best single measure of the work load being per-
formed; hence, exercise limitations caused by the abnormalities
of gas exchange or inappropriate cardiovascular responses
may be qualiﬁed by relating speciﬁc parameters to oxygen con-
sumption [9].
In our study, the comparison of oxygen saturation percent
(SpO2 %) between the different groups of cirrhotic patients
showed signiﬁcant difference between groups (A, B), (A, C)
and (B, C) regarding SpO2 %.(Table 4) .The above result coin-
cides with Rabinovich et al. (2002) who studied SpO2 % in 27
patients with liver cirrhosis. These patients were separated into
two groups, group I: compensated liver diseases and group II:
decompensated, he found that SpO2 % was much reduced in
group II 2.01 ± 0.52 versus 3.62 ± 0.29 in group I [10].Conclusion
1. Cirrhotic patients have impaired exercise performance.
2. Prevalence of exercise impairment increased with the
increase of the severity of liver cirrhosis.
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